The center is participating in a research study of migraine headaches in adults. The purpose of this study is to learn how safe and useful the study medicine is for treating migraine pain when the medication is taken early, before migraine pain is moderate to severe. This medicine is approved by the FDA for treating migraine headache pain. This study medicine will be used to treat only one migraine headache.
Participants have six weeks from the time the study starts to have and treat a migraine headache.
Participants must agree to see the study doctor two times and must be willing to keep a diary. If you would like to learn more about participating in this study, please send an e-mail message using the form below. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research.